Rankings
▼
Calendar
EW FY 2017 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena
EW
Edwards Lifesciences Corporation
$49B
FY 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$3.4B
+15.9% YoY
Gross Profit
$2.6B
74.3% margin
Operating Income
$1.0B
29.4% margin
Net Income
$622M
18.1% margin
EPS (Diluted)
$0.96
Cash Flow
Operating Cash Flow
$1.0B
Free Cash Flow
$825M
Stock-Based Comp.
$62M
Balance Sheet
Total Assets
$5.7B
Total Liabilities
$2.7B
Stockholders' Equity
$3.0B
Cash & Equivalents
$818M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.4B
$3.0B
+15.9%
Gross Profit
$2.6B
$2.2B
+18.3%
Operating Income
$1.0B
$816M
+23.9%
Net Income
$622M
$570M
+9.2%
← Q4 2016
All Quarters
Q1 2017 →